Rachel L. Graham, Ph.D.
Affiliations: | 2006 | Vanderbilt University, Nashville, TN |
Area:
MicrobiologyGoogle:
"Rachel Graham"Parents
Sign in to add mentorMark R. Denison | grad student | 2006 | Vanderbilt | |
(Papain -like proteinase mediated processing and the role of intermediate and mature replicase proteins in coronavirus replication.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Alzhanova D, Corcoran K, Bailey AG, et al. (2021) Novel modulators of p53-signaling encoded by unknown genes of emerging viruses. Plos Pathogens. 17: e1009033 |
Edwards CE, Yount BL, Graham RL, et al. (2020) Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. Proceedings of the National Academy of Sciences of the United States of America |
Mallory ML, Lindesmith LC, Brewer-Jensen PD, et al. (2020) Bile Facilitates Human Norovirus Interactions with Diverse Histoblood Group Antigens, Compensating for Capsid Microvariation Observed in 2016-2017 GII.2 Strains. Viruses. 12 |
Pruijssers AJ, George AS, Schäfer A, et al. (2020) Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice. Cell Reports. 107940 |
Menachery VD, Yount BL, Debbink K, et al. (2020) Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature Medicine. 26: 1146 |
Sanders W, Fritch EJ, Madden EA, et al. (2020) Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses. Biorxiv : the Preprint Server For Biology |
Pruijssers AJ, George AS, Schäfer A, et al. (2020) Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Biorxiv : the Preprint Server For Biology |
Graham RL, Baric RS. (2020) SARS-CoV-2: Combating Coronavirus Emergence. Immunity |
Tse LV, Meganck RM, Graham RL, et al. (2020) The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Frontiers in Microbiology. 11: 658 |
Sheahan TP, Sims AC, Zhou S, et al. (2020) An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science Translational Medicine |